ND2 EVALUATIONS OF THE PRESCRIBED DAILY DOSES OF TRANSDERMAL FENTANYL AND TRANSDERMAL BUPRENORPHINE IN CANCERAND NON-CANCER PATIENTS IN GERMANY- RESULTS FROM A RETROSPECTIVE DATABASE ANALYSIS
Abstract
Authors
G Haerdtl U Niemann MC Nuijten B Poulsen Nautrup